Published on

Infectious Disease and Microbiology - Whipple’s Disease

Basics

Description

Whipple’s disease is a rare, chronic, multisystem infection caused by Tropheryma whipplei. The disease classically affects the small intestine but can involve many organs, including the joints, central nervous system, heart, lungs, liver, kidneys, and lymphatic system.

Typical manifestations include:

  • Weight loss
  • Chronic diarrhea
  • Malabsorption
  • Abdominal pain
  • Lymphadenopathy
  • Migratory arthralgia or arthritis
  • Neurologic abnormalities

Untreated disease can be fatal, particularly when the central nervous system or heart is involved.

⸻

Epidemiology

Whipple’s disease is very uncommon.

Only a relatively small number of clinically recognized cases have been reported worldwide, with most cases described in:

  • Western Europe
  • North America

The disease most often affects:

  • Middle-aged adults
  • Men much more commonly than women
  • Historically, white European populations

Exposure to T. whipplei appears to be much more common than actual Whipple’s disease, suggesting that host immune factors contribute strongly to disease development.

⸻

Risk Factors

Important associations include:

  • Male sex
  • Middle age
  • Possible occupational or environmental exposure to sewage or wastewater
  • Certain abnormalities in cell-mediated immune responses
  • Immunosuppressive therapy

Symptoms may worsen dramatically after treatment with:

  • Corticosteroids
  • Other immunosuppressive agents

This can occur when Whipple’s disease has been mistaken for an inflammatory or rheumatologic disorder.

⸻

Genetics

Certain host genetic factors have been investigated, including associations with specific HLA patterns.

Older literature described an association with HLA-B27, although no single genetic marker is sufficiently specific to diagnose or predict Whipple’s disease.

⸻

Etiology

The causative organism is:

Tropheryma whipplei

It is:

  • A gram-positive actinomycete-related bacterium
  • Intracellular
  • Non-acid-fast
  • Detectable by periodic acid-Schiff staining in infected tissue

The organism can be found in several tissues, including:

  • Small bowel
  • Lymph nodes
  • Heart valves
  • Synovium
  • Brain
  • Liver
  • Lungs
  • Kidneys

⸻

Pathophysiology

T. whipplei infects macrophages and accumulates within tissues.

In the small intestine, infected macrophages infiltrate the lamina propria and interfere with normal intestinal architecture and nutrient absorption.

This produces:

  • Villous dysfunction
  • Malabsorption
  • Steatorrhea
  • Weight loss
  • Nutritional deficiencies

The organism can disseminate hematogenously or through lymphatic pathways to multiple organs.

A notable feature is that the tissue response may be relatively weak despite substantial organism burden.

⸻

Clinical Course

Whipple’s disease often evolves through two broad phases.

Prodromal Phase

This stage may last for years.

The most characteristic early symptoms are:

  • Migratory arthralgias
  • Intermittent arthritis

Joint symptoms often precede gastrointestinal symptoms by several years.

The arthritis is typically:

  • Migratory
  • Episodic
  • Nondestructive
  • Seronegative

⸻

Established Systemic Disease

Later, patients may develop:

  • Weight loss
  • Chronic diarrhea
  • Steatorrhea
  • Abdominal pain
  • Fever
  • Lymphadenopathy
  • Neurologic disease
  • Cardiac involvement

The interval between early joint symptoms and overt gastrointestinal disease may be several years.

⸻

Gastrointestinal Manifestations

Classic gastrointestinal features include:

  • Chronic diarrhea
  • Steatorrhea
  • Abdominal pain
  • Abdominal distention
  • Weight loss
  • Malabsorption

Occult gastrointestinal blood loss may occur.

Frank hematochezia is uncommon.

Consequences of malabsorption may include:

  • Anemia
  • Vitamin deficiencies
  • Hypoalbuminemia
  • Coagulopathy from vitamin K deficiency
  • Muscle wasting

⸻

Musculoskeletal Manifestations

Joint disease is one of the most important early clues.

Typical features include:

  • Migratory arthralgia
  • Intermittent arthritis
  • Large-joint involvement
  • Nondestructive course

Joint symptoms may precede intestinal disease by years.

This pattern can lead to misdiagnosis as:

  • Rheumatoid arthritis
  • Reactive arthritis
  • Other inflammatory arthritides

Immunosuppressive therapy given for an incorrect rheumatologic diagnosis may accelerate progression.

⸻

Constitutional Features

Patients may develop:

  • Fever
  • Fatigue
  • Malaise
  • Cachexia
  • Muscle wasting

Hypotension may occur in advanced disease.

⸻

Lymphatic and Reticuloendothelial Manifestations

Possible findings include:

  • Peripheral lymphadenopathy
  • Abdominal lymphadenopathy
  • Hepatomegaly
  • Splenomegaly

Lymph nodes are often enlarged but not necessarily painful.

⸻

Skin Manifestations

Skin hyperpigmentation may occur.

This can be related to:

  • Chronic illness
  • Nutritional abnormalities
  • Adrenal dysfunction

⸻

Neurologic Involvement

Central nervous system involvement is particularly important because it worsens prognosis and increases relapse risk.

Neurologic manifestations may include:

  • Cognitive impairment
  • Dementia
  • Personality change
  • Depression
  • Confusion
  • Cerebellar ataxia
  • Seizures
  • Nystagmus
  • Myoclonus
  • Supranuclear ophthalmoplegia

Hypothalamic involvement may produce:

  • Polydipsia
  • Hyperphagia
  • Decreased libido
  • Amenorrhea
  • Sleep abnormalities

⸻

Characteristic Neurologic Signs

A particularly characteristic but uncommon feature is:

Oculomasticatory myorhythmia

This consists of rhythmic eye movements accompanied by synchronous movements of the jaw or facial muscles.

When present, it is highly suggestive of CNS Whipple’s disease.

⸻

Ocular Manifestations

Possible ocular findings include:

  • Uveitis
  • Retinitis
  • Ophthalmoplegia
  • Nystagmus

⸻

Cardiac Manifestations

Cardiac involvement may include:

  • Endocarditis
  • Pericarditis
  • Myocarditis
  • Valvular disease

T. whipplei is an important cause of:

Culture-negative endocarditis

Importantly, Whipple endocarditis may occur without obvious:

  • Diarrhea
  • Weight loss
  • Classic intestinal manifestations

Patients may present only with:

  • Heart murmur
  • Embolic events
  • Heart failure
  • Constitutional symptoms

⸻

Pulmonary Manifestations

Possible respiratory manifestations include:

  • Dyspnea
  • Pleural effusion
  • Pulmonary infiltrates

These findings are usually nonspecific.

⸻

Adrenal and Endocrine Manifestations

Adrenal involvement may produce features of adrenal insufficiency.

Possible findings include:

  • Hypotension
  • Hyperpigmentation
  • Weakness
  • Electrolyte abnormalities

⸻

Physical Examination

Possible examination findings include:

  • Cachexia
  • Muscle wasting
  • Abdominal distention
  • Ascites
  • Hepatomegaly
  • Splenomegaly
  • Peripheral lymphadenopathy
  • Hyperpigmentation
  • Cardiac murmur
  • Neurologic deficits

Oral nutritional abnormalities may include:

  • Glossitis
  • Angular cheilitis

⸻

Diagnosis

Diagnosis requires a combination of:

  • Clinical suspicion
  • Histopathology
  • Molecular testing

The classic diagnostic approach is:

Small-bowel biopsy showing PAS-positive macrophages

with confirmation by:

PCR for T. whipplei

⸻

Laboratory Findings

Possible laboratory abnormalities include:

  • Anemia
  • Leukocytosis
  • Lymphopenia
  • Thrombocytosis
  • Elevated inflammatory markers
  • Hypoalbuminemia
  • Prolonged prothrombin time
  • Nutritional deficiencies

Prolonged PT may result from:

Vitamin K malabsorption

Eosinophilia may occasionally occur but is not a characteristic finding.

⸻

Cerebrospinal Fluid

In CNS disease, CSF may demonstrate:

  • Pleocytosis
  • Elevated protein

However, routine CSF findings are nonspecific.

PCR of CSF for T. whipplei is much more important when neurologic disease is suspected.

⸻

Small-Bowel Biopsy

Upper gastrointestinal endoscopy with multiple duodenal or jejunal biopsies is a classic diagnostic procedure.

Histology typically demonstrates:

Foamy macrophages within the lamina propria containing PAS-positive material

Multiple biopsies should be obtained because involvement can be patchy.

⸻

Histopathology

The hallmark finding is:

PAS-positive macrophages in the lamina propria

The macrophages contain magenta-staining intracellular material derived from the organism.

Additional confirmation with:

  • Immunohistochemistry
  • PCR

helps distinguish Whipple’s disease from other conditions with PAS-positive macrophages.

⸻

PCR

PCR is highly useful for detecting T. whipplei DNA.

Samples may include:

  • Small-bowel tissue
  • Lymph-node tissue
  • Synovial tissue
  • Cardiac valve tissue
  • CSF
  • Blood

Saliva and stool PCR may also detect the organism.

However:

Positive saliva or stool PCR alone does not establish Whipple’s disease

because asymptomatic carriage can occur.

⸻

CNS Testing

When CNS involvement is suspected:

CSF PCR should be performed

even if neurologic symptoms are subtle.

CNS infection may persist despite apparent gastrointestinal improvement.

⸻

Culture

T. whipplei can be cultured in specialized laboratories.

However:

  • Growth is slow
  • Culture is technically difficult
  • It is not routinely required for diagnosis

⸻

Serology

Serologic testing is generally not useful for routine diagnosis.

Antibody responses may be unreliable and can occur in asymptomatic carriers.

⸻

Imaging

Imaging findings are usually nonspecific.

Possible studies include:

Chest radiography

May show:

  • Pleural effusion
  • Nonspecific pulmonary abnormalities

Abdominal CT

May demonstrate:

  • Mesenteric lymphadenopathy
  • Bowel-wall abnormalities
  • Ascites

Brain MRI

May show nonspecific abnormalities on:

  • T1
  • T2
  • FLAIR sequences

Imaging cannot reliably establish the diagnosis.

⸻

Differential Diagnosis

Whipple’s disease can mimic numerous gastrointestinal, infectious, rheumatologic, and neurologic disorders.

Important differentials include:

  • Celiac disease
  • Inflammatory bowel disease
  • Small-bowel lymphoma
  • Sarcoidosis
  • Mycobacterial infection
  • HIV enteropathy
  • Reactive arthritis
  • Autoimmune disease
  • Familial Mediterranean fever
  • Infective endocarditis
  • Hyperthyroidism
  • Neurosarcoidosis
  • Neurosyphilis
  • Neurodegenerative disease

⸻

Whipple’s Disease vs Mycobacterium avium Complex

Both conditions can show macrophage infiltration of the small intestine.

However:

Whipple’s disease

→ PAS-positive macrophages

→ Acid-fast stain negative

Mycobacterium avium complex

→ Acid-fast organisms present

This is a useful diagnostic distinction.

⸻

Treatment Principles

Whipple’s disease requires prolonged antimicrobial therapy because the organism:

  • Disseminates widely
  • Can involve the CNS
  • May persist intracellularly
  • Can relapse years after treatment

Therapy should include agents with:

Good CNS penetration

even when neurologic symptoms are absent.

⸻

Initial Treatment

A commonly used approach begins with a CNS-penetrating intravenous antibiotic for approximately 2 weeks.

Options may include:

  • Ceftriaxone
  • Meropenem

The purpose is to rapidly reduce systemic and CNS organism burden.

More prolonged initial IV treatment may be considered for:

  • Endocarditis
  • CNS disease
  • Relapse
  • Severe disseminated infection

⸻

Long-Term Treatment

After induction therapy, prolonged oral treatment is required.

Historically, trimethoprim-sulfamethoxazole was widely used.

However, contemporary practice increasingly favors regimens such as:

Doxycycline plus hydroxychloroquine

for prolonged therapy because of concerns regarding intrinsic or acquired resistance patterns and relapse with trimethoprim-sulfamethoxazole.

Treatment often continues for approximately:

12 months or longer

depending on disease site and response.

Specialist infectious-disease management is strongly recommended.

⸻

Doxycycline Plus Hydroxychloroquine

A commonly used oral combination is:

  • Doxycycline
  • Hydroxychloroquine

Hydroxychloroquine alkalinizes the phagolysosome and improves the activity of doxycycline against intracellular T. whipplei.

Long courses are required.

Monitoring is necessary for hydroxychloroquine toxicity, particularly:

  • Retinal toxicity
  • Cardiac effects in selected patients

⸻

CNS Disease

Neurologic Whipple’s disease requires especially aggressive and prolonged treatment.

Important considerations include:

  • CNS-penetrating induction therapy
  • Long-term antimicrobial treatment
  • Serial neurologic evaluation
  • CSF PCR monitoring in selected cases

Relapse may occur years later.

⸻

Endocarditis

Whipple endocarditis should be treated with prolonged antimicrobial therapy.

Valve replacement may be necessary if there is:

  • Severe valve destruction
  • Heart failure
  • Persistent infection
  • Major hemodynamic compromise

Not every case automatically requires valve surgery; management depends on standard endocarditis surgical indications.

⸻

Corticosteroids

Corticosteroids are generally not routine treatment for Whipple’s disease.

They may occasionally be considered in selected severe inflammatory complications under specialist supervision.

Unrecognized Whipple’s disease can worsen substantially when immunosuppressive therapy is administered without effective antimicrobial treatment.

⸻

Immune Reconstitution Inflammatory Syndrome

After antimicrobial therapy begins, some patients develop paradoxical inflammatory worsening.

This may present with:

  • High fever
  • New inflammatory lesions
  • Clinical deterioration despite microbiologic treatment

This resembles an immune reconstitution inflammatory syndrome.

It appears particularly in patients with neurologic involvement or prior immunosuppression.

⸻

Jarisch-Herxheimer-Like Reaction

A transient inflammatory reaction has occasionally been described shortly after antibiotic initiation.

Possible manifestations include:

  • Fever
  • Chills
  • Clinical worsening

Careful observation is appropriate, particularly during initial therapy.

⸻

Follow-Up

Long-term follow-up is essential.

Monitoring should include:

  • Weight
  • Gastrointestinal symptoms
  • Neurologic status
  • Joint symptoms
  • Cardiac findings
  • Nutritional status

PCR may help assess treatment response in selected cases.

Histologic abnormalities can persist after successful therapy, so persistent PAS-positive macrophages do not always indicate active infection.

⸻

Relapse

Relapse is a major concern.

It may occur:

  • Months later
  • Years later
  • Even after apparently successful treatment

Relapse commonly involves:

The central nervous system

Therefore new neurologic symptoms in a previously treated patient should prompt urgent investigation.

⸻

Diet and Nutritional Support

No specific diet treats Whipple’s disease.

However, malabsorption may require replacement of:

  • Fat-soluble vitamins
  • Iron
  • Folate
  • Vitamin B12
  • Electrolytes
  • Protein and calories

Nutritional rehabilitation is important in severely wasted patients.

⸻

Prognosis

With appropriate diagnosis and prolonged antimicrobial treatment, prognosis is generally favorable.

Without treatment, the disease is ultimately fatal.

Poorer outcomes are associated with:

  • CNS involvement
  • Delayed diagnosis
  • Severe cardiac disease
  • Relapse
  • Inappropriate immunosuppression

⸻

Complications

Important complications include:

  • Severe malabsorption
  • Cachexia
  • Vitamin deficiencies
  • Neurologic deterioration
  • Dementia
  • Seizures
  • Ophthalmoplegia
  • Culture-negative endocarditis
  • Heart failure
  • Pericarditis
  • Myocarditis
  • Relapse

⸻

High-Yield Clinical Pattern

Years of migratory arthralgia followed by weight loss and chronic diarrhea

→ Think Whipple’s disease

⸻

High-Yield Diagnostic Pattern

Small-bowel biopsy + PAS-positive foamy macrophages

→ Strongly suggestive of Whipple’s disease

Confirmation:

→ T. whipplei PCR

⸻

High-Yield Cardiac Pattern

Culture-negative endocarditis + negative routine cultures + systemic or arthritic history

→ Consider Tropheryma whipplei

⸻

High-Yield Neurologic Pattern

Cognitive decline + ophthalmoplegia + myoclonus in systemic Whipple’s disease

→ CNS involvement

Characteristic finding:

→ Oculomasticatory myorhythmia

⸻

Exam Essentials

Causative organism:

→ Tropheryma whipplei

Organism type:

→ Actinomycete-related gram-positive bacterium

Classic patient:

→ Middle-aged man

Classic early manifestation:

→ Migratory arthralgia/arthritis

Classic later manifestations:

→ Weight loss + diarrhea + malabsorption

Classic biopsy:

→ PAS-positive macrophages in small-bowel lamina propria

Acid-fast stain:

→ Negative

Confirmatory test:

→ PCR for T. whipplei

Important cardiac manifestation:

→ Culture-negative endocarditis

Important neurologic complication:

→ CNS Whipple’s disease

Characteristic neurologic sign:

→ Oculomasticatory myorhythmia

Treatment principle:

→ Initial CNS-penetrating antibiotics followed by prolonged oral therapy

Important clinical warning:

→ Immunosuppressive therapy can markedly worsen undiagnosed disease

Major long-term concern:

→ Relapse, particularly in the CNS


Image description
0 Comments